News

From our CEO

25 July 2023

Rohan Greenland The May 50K

You could be forgiven if you missed World Brain Day on July 22.

It certainly deserves much more attention, especially by our politicians. An initiative of the World Federation of Neurology, it helps promote the concept of brain health.

Here in Australia, we know that around one-in-six people have a neurological or neuromuscular condition.

Despite these very significant numbers, we don’t have a national neurological action plan, nor do we know what the Australian Government is doing to implement the 2022 Global Action Plan for Neurological Disorders.

The need for action is clear.

The Neurological Alliance Australia, which we currently Chair, and MS Australia are calling for:

  • A national neurological research mission within the Medical Research Future Fund (neurological research is under-funded)
  • A national minimum data set for neurological conditions (unbelievably, there is no national data set)
  • A neurological advisory group to improve access and equity to the NDIS
  • Better investment in public health, including a focus on brain health, and
  • An urgent boost in the number of MS nurses.

Most of the major disease groups have dedicated action plans, research initiatives and data collections. But neurological conditions are being left behind, even though more than four million Australians are living with one or more of these disorders.

Time for change. Time for action.

Related News

MS News

From our CEO

28 October 2026

CEO Rohan Greenland reflects on 30 years of progress in MS treatment and why, amid the current PBAC review, protecting treatment choice and access is vital for the future.

MS News

Understanding MS diagnosis and misdiagnosis

28 October 2026

Christina Applegate’s recent experience has raised questions about MS misdiagnosis. We look at how MS is diagnosed, why misdiagnosis can occur and the progress being made to help people get accurate answers and appropriate care and support.

MS News

Unifying MS – research updates from MSToronto2026

28 October 2026

The latest in MS diagnosis, therapies, clinical trials, care and science was presented at the world’s largest conference on MS and related disorders in Toronto, Canada, in October 2026.

Read More
WHO three MS medicines added to EML

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

From our CEO